FLASH THERAPEUTICS
Toulouse / 3 Avenue Hubert Curien
|
Flash Therapeutics is a biotech company that designs, develops and manufactures DNA and RNA transfer technologies dedicated to innovative cell and gene therapies. Through its scalable bioproduction processes, the company offers a manufacturing continuum (from discovery to therapy) to accelerate proof of concept for new drugs in the clinic. In particular, the LentiFlash® delivery technology mediated by a lentiviral particle transporting exclusively RNAs, is dedicated to vaccination studies, gene editing and other therapeutic approaches. |
|||||||||
| Business axis : |
Medicine
|
||||||||
| Category : | PME | ||||||||
| Legal form : | SAS | ||||||||
| Website : | https://www.flashtherapeutics.com/ | ||||||||
| Turnover : |
3,283,067.00 K€ |
||||||||
Contact : |
|||||||||
ICHE AlexandraGene Engineering Project Manager |
|||||||||
| Email : | alexandra.iche@flashtherapeutics.com | ||||||||
LAMOUROUX LucilleGene Engineering Manager |
|||||||||
| Email : | lucille.lamouroux@vectalys.com | ||||||||
BOUILLE PascaleCEO |
|||||||||
| Email : | pascale.bouille@flashtherapeutics.com | ||||||||
DUTHOIT Christinechef de projet ingénierie cellulaire et immunologie |
|||||||||
| Email : | christine.duthoit@flashtherapeutics.com | ||||||||
DARRIGAN SandyContrats & Intellectual Property Manager |
|||||||||
| Email : | sandy.darrigan@flashtherapeutics.com | ||||||||